This review describes research using the Promega BDNF Emax® ImmunoAssay System in a continuous medium-withdrawal method for measuring BDNF release from NMDA-treated neurons. This method was initially developed by Ann M. Marini and colleagues in 1998 in a landmark paper for ELISA-based neurotrophin detection.
Cell Notes 19, 6–7.
Download Article (65 KB)
Your country is set to Spain. Your language is set to español. Please select the language that will best suit your needs:
This is correct, continue to site »
I need additional help